Mi Jianqing

Title: Chief Physician, Professor, Doctoral Supervisor

Hospital: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Department: Director, Department of Hematology

Areas of Expertise: Lymphoid neoplasms, multiple myeloma, CAR-T cell therapy

Expert Profile

A renowned expert in the field of hematologic oncology in China, he currently serves as Director of the Hematology Department at Ruijin Hospital, and is a member of the Hematology Branch of the Chinese Medical Association. With over 30 years of medical practice, he has profound mastery in the diagnosis and treatment of hematologic malignancies such as lymphoid neoplasms and multiple myeloma. He pioneered the implementation of CAR-T cell therapy technology in China, achieving breakthrough results in immunotherapy for relapsed/refractory hematologic malignancies. He has published over 100 academic papers, including more than 50 indexed in SCI. He has presided over multiple National Natural Science Foundation of China grants and Shanghai municipal key research projects, and has received awards including the Second Prize of the Chinese Medical Science and Technology Award and the First Prize of the Shanghai Science and Technology Progress Award.

Visit Guide

• Book through the China International Medical Service System for green channel access
• Full-time translation and escort service provided
• Assistance with hospitalization, examination, surgery, and other procedures
• Post-operative rehabilitation follow-up and remote consultation